tiprankstipranks
Trending News
More News >
Amdocs (DOX)
NASDAQ:DOX
Advertisement

Amdocs (DOX) AI Stock Analysis

Compare
526 Followers

Top Page

DOX

Amdocs

(NASDAQ:DOX)

Rating:73Outperform
Price Target:
$99.00
▲(11.40% Upside)
Amdocs' overall stock score reflects its solid financial performance and strong earnings call results, which highlight growth in managed services and cloud initiatives. The technical analysis indicates a neutral trend, while the valuation suggests the stock is fairly priced. The company's strategic initiatives in AI and cloud, along with a robust free cash flow, position it well for future growth despite some macroeconomic uncertainties.
Positive Factors
Cloud Growth
Cloud initiatives continue to generate most of the growth, with cloud accounting for over 25% of revenues and growing at a double-digit rate.
Financial Performance
Operating margin of 21.2% increased by 310 basis points year-over-year, driven by the phasing out of non-core businesses and operating efficiencies.
Revenue Visibility
Backlog increased by $80 million quarter-over-quarter and 3.5% year-over-year on a pro forma constant currency basis, providing nearly 90% visibility for next year's revenues.
Negative Factors
Industry Challenges
The company noted continued industry spending challenges, contributing to a challenging core underlying growth.
Macro Environment
There has been no significant shift in the sluggish business trends, and the company is still experiencing an unfavorable macro environment.
Revenue Headwind
The business will face lower growth and a $600 million revenue headwind due to the discontinuation of low-margin businesses.

Amdocs (DOX) vs. SPDR S&P 500 ETF (SPY)

Amdocs Business Overview & Revenue Model

Company DescriptionAmdocs Limited, through its subsidiaries, provides software and services worldwide. The company designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. It provides CES21, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; the Commerce and Care suite for order capture, handling, and customer engagement; the Monetization suite for charging, billing, policy, and revenue management; Intelligent Networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; MarketONE, a cloud-native business ecosystem; Digital Brands Suite, a pre-integrated digital business suite for digital telecom brands and small-scale service providers; and eSIM Cloud for service providers. It also offers AI-powered, cloud-native, and home operating systems; data intelligence solutions and applications; media services for media publishers, TV networks, and video streaming and service providers; end-to-end application development and maintenance services; and ongoing services. In addition, the company provides a line of services designed for various stages of a service provider's lifecycle includes design, delivery, quality engineering, operations, systems integration, mobile network services, consulting, and content services; managed services comprising application development, modernization and maintenance, IT and infrastructure services, testing and professional services that are designed to assist customers in the selection, implementation, operation, management, and maintenance of IT systems. It serves to the communications, cable and satellite, entertainment, and media industry service providers, as well as mobile virtual network operators and directory publishers. Amdocs Limited was founded in 1988 and is headquartered in Saint Louis, Missouri.
How the Company Makes MoneyAmdocs makes money primarily through the sale of software licenses, managed services, and consulting services to telecommunications and media companies. Its revenue model is built on long-term contracts with large service providers, which include the sale of software solutions and ongoing maintenance and support services. The company also generates revenue from professional services, including project management, implementation, and integration services. Additionally, Amdocs benefits from significant partnerships with leading telecom operators and technology providers, allowing it to expand its market reach and enhance its product offerings. These partnerships, along with its strong focus on innovation and customer satisfaction, contribute significantly to its earnings.

Amdocs Earnings Call Summary

Earnings Call Date:Aug 06, 2025
(Q2-2025)
|
% Change Since: 5.08%|
Next Earnings Date:Nov 18, 2025
Earnings Call Sentiment Positive
The earnings call highlighted strong financial performance, with revenue and profitability exceeding expectations. Amdocs demonstrated robust growth in managed services and cloud initiatives, and made significant advancements in AI and GenAI capabilities. However, challenges such as foreign currency impacts and mixed trends in certain regions were noted, amidst a backdrop of increasing macroeconomic uncertainty.
Q2-2025 Updates
Positive Updates
Revenue Growth Above Guidance
Revenue of $1.13 billion was above the midpoint of guidance and increased by 4% from a year ago in pro forma constant currency.
Improved Profitability
Profitability improved by 10 basis points sequentially, reflecting ongoing internal efficiency gains.
Strong Free Cash Flow
Generated robust free cash flow of $181 million, excluding restructuring-related payments, supported by healthy customer cash collection.
12-Month Backlog Increase
Closed the second quarter with a 12-month backlog of $4.17 billion, up by 3.5% pro forma from a year ago.
Managed Services Record
Delivered another record quarter in managed services, which contributed roughly two-thirds of total revenue.
Cloud and AI Initiatives
Continued strong sales momentum in cloud and announced major cloud projects with Microsoft and other leading operators.
AI and GenAI Advancements
Amdocs' amAIz platform and collaboration with NVIDIA highlighted as significant advancements, with multiple PoCs in advanced stages.
Share Repurchase Authorization
Board authorized a new share repurchase plan of $1 billion, with $1.26 billion of remaining repurchase authority as of March 31.
Negative Updates
Foreign Currency Impact
Revenue was impacted by a negative foreign currency movement of approximately $2 million compared to guidance assumptions.
Mixed Trends in Latin America
Despite healthy customer activity in Southeast Asia, mixed trends in Latin America resulted in a sequential decline in rest of the world.
Macroeconomic Uncertainty
Level of global macroeconomic uncertainty is rising, but Amdocs believes it is relatively well-positioned to navigate the current environment.
Company Guidance
During the Amdocs Second Quarter 2025 Earnings Conference Call, the company provided guidance reflecting positive performance and strategic growth. Amdocs reported revenue of $1.13 billion, a 4% year-over-year increase in pro forma constant currency, and a 10 basis point sequential improvement in profitability. The call highlighted a robust free cash flow of $181 million, excluding restructuring payments, and non-GAAP earnings per share of $1.78, surpassing the guidance range. The 12-month backlog increased by 3.5% pro forma to $4.17 billion. Amdocs remains on track to achieve double-digit growth in cloud-related revenue and reiterated its fiscal 2025 revenue growth outlook of 2.7% at the midpoint. The company emphasized ongoing strategic initiatives, including cloud migration projects, AI developments, and digital transformation efforts. Amdocs also announced a new $1 billion share repurchase plan and expects to return the majority of free cash flow to shareholders, projecting free cash flow between $710 million and $730 million for the fiscal year.

Amdocs Financial Statement Overview

Summary
Amdocs exhibits solid financial health with stable profitability and effective cash flow management. While revenue growth has been underwhelming, cost controls and leverage are well-maintained. The company is in a strong equity position with manageable debt levels. Focus on enhancing revenue growth and optimizing asset utilization could improve performance.
Income Statement
72
Positive
Amdocs' income statement shows a stable performance with a decent gross profit margin and consistent EBIT and EBITDA margins. The TTM data reveals a slight decline in total revenue compared to the previous period, indicating a potential stagnation in revenue growth. However, the company maintains a healthy net profit margin, reflecting efficient cost management. The overall income statement suggests moderate profitability with room for revenue growth improvement.
Balance Sheet
68
Positive
The balance sheet reflects a strong equity position with a good equity ratio, indicating financial stability. The debt-to-equity ratio is reasonable, suggesting manageable leverage levels. However, the ROE has shown some variability, indicating fluctuating returns to shareholders. Overall, the balance sheet is robust, but optimizing asset utilization could enhance performance.
Cash Flow
75
Positive
Amdocs demonstrates strong cash flow management, with a healthy operating cash flow to net income ratio, indicating efficient operational performance. The free cash flow remains positive, albeit with a slight decrease in growth rate, which could impact future investment capabilities. However, the company appears to effectively manage its cash flows, maintaining flexibility for strategic initiatives.
BreakdownSep 2024Sep 2023Sep 2022Sep 2021Sep 2020
Income Statement
Total Revenue5.00B4.89B4.58B4.29B4.17B
Gross Profit1.76B1.73B1.62B1.48B1.41B
EBITDA819.03M855.15M889.85M1.04B792.16M
Net Income493.20M540.71M549.50M688.37M497.84M
Balance Sheet
Total Assets6.39B6.43B6.39B6.51B6.34B
Cash, Cash Equivalents and Short-Term Investments514.33M742.53M817.98M965.59M983.94M
Total Debt789.74M807.31M826.83M881.17M1.03B
Total Liabilities2.89B2.86B2.83B2.88B2.68B
Stockholders Equity3.46B3.52B3.52B3.59B3.62B
Cash Flow
Free Cash Flow618.93M698.27M529.50M715.37M452.63M
Operating Cash Flow724.43M822.63M756.72M925.81M658.14M
Investing Cash Flow-127.41M-224.50M-262.50M-329.00M-461.73M
Financing Cash Flow-771.02M-651.43M-629.90M-870.93M315.14M

Amdocs Technical Analysis

Technical Analysis Sentiment
Positive
Last Price88.87
Price Trends
50DMA
89.94
Negative
100DMA
88.82
Positive
200DMA
87.35
Positive
Market Momentum
MACD
-1.19
Positive
RSI
53.37
Neutral
STOCH
38.19
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DOX, the sentiment is Positive. The current price of 88.87 is above the 20-day moving average (MA) of 87.49, below the 50-day MA of 89.94, and above the 200-day MA of 87.35, indicating a neutral trend. The MACD of -1.19 indicates Positive momentum. The RSI at 53.37 is Neutral, neither overbought nor oversold. The STOCH value of 38.19 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DOX.

Amdocs Risk Analysis

Amdocs disclosed 29 risk factors in its most recent earnings report. Amdocs reported the most risks in the "Tech & Innovation" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Amdocs Peers Comparison

Overall Rating
UnderperformOutperform
Sector (69)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
$9.43B17.7515.83%2.26%-4.37%7.18%
73
Outperform
$10.89B25.229.82%3.51%-27.28%
69
Neutral
¥233.77B14.287.64%2.58%9.19%5.32%
67
Neutral
$8.47B-6.42%33.17%82.85%
66
Neutral
$7.36B17.42-60.11%0.79%0.59%
58
Neutral
$16.94B218.28%43.89%49.74%
46
Neutral
$10.85B-11.15%23.16%-9.81%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
DOX
Amdocs
88.87
6.81
8.30%
AKAM
Akamai
74.76
-16.81
-18.36%
DBX
Dropbox
26.20
4.47
20.57%
KVYO
Klaviyo, Inc. Class A
34.03
3.25
10.56%
RBRK
Rubrik, Inc. Class A
89.74
58.25
184.98%
SAIL
SailPoint, Inc.
20.03
-4.52
-18.41%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 08, 2025